December 15, 2017 A new study from The Wistar Institute revealed the mechanism implicated in the defective function of tumor-associated dendritic cells (DCs), a specialized type of immune cells that expose the antigens on their surface to activate the T cells. The new findings explain why DCs are not effective in executing a specialized process […]Continue Reading ...
Cancer changes everything — even when it invades the personal life of an oncologist. (ASCO Connection) Despite significant progress in breast, ovarian, and colon cancer, outcomes in minority patients, especially African Americans, still lag. (Cancer) Patients with HIV-associated lymphoma can safely continue HIV therapy during chemotherapy. (Fox Chase Cancer Center) Immunotherapy-containing combination treatment significantly reduced […]Continue Reading ...
December 13, 2017 For patients with advanced leukemia, access to high-quality end-of-life care appears to be reduced in those dependent on blood transfusions, according to a new study being presented during the 59th American Society of Hematology (ASH) Annual Meeting and Exposition in Atlanta. The study associates this reduced access and consequent diminished use of […]Continue Reading ...
FDA Approves Ixifi (infliximab-qbtx), a Biosimilar to Remicade December 13, 2017 — Pfizer Inc. (NYSE:PFE) announced today that the United States (U.S.) Food and Drug Administration (FDA) has approved Ixifi (PF-06438179, infliximab-qbtx), a chimeric human-murine monoclonal antibody (mAb) against tumor necrosis factor, as a biosimilar to Remicade® (infliximab)* for all eligible indications of the reference […]Continue Reading ...
Dr. Scott Lilly performs a heart catheterization on Janet Wickham at The Ohio State University Wexner Medical Center as part of a study to investigate a new device for diastolic heart failure. Credit: The Ohio State University Wexner Medical Center Results presented today at the American Heart Association Scientific Sessions and published in Circulation show […]Continue Reading ...
December 14, 2017 A new study led by scientists at the University of Southampton has found that inherited variation in a particular gene may be to blame for the lower survival rate of patients diagnosed with early-onset breast cancer. Breast cancer is the second leading cause of cancer-related death in women, with nearly 450,000 deaths […]Continue Reading ...
WEDNESDAY, Dec. 13, 2017 — Raising one particular tax just might have a public health benefit. The tax in question? States’ alcohol excise tax. In the United States, those taxes have not kept pace with inflation, which could limit their public health benefits, researchers report. In inflation-adjusted dollars, the average state alcohol excise tax has […]Continue Reading ...
WEDNESDAY, Dec. 13, 2017 (HealthDay News) — Many people insist their joints ache more when it rains. But that popular notion might be all wet, a new study suggests. The study of more than 1.5 million older Americans found that people were no more likely to visit the doctor with joint or back pain during […]Continue Reading ...
Credit: CC0 Public Domain UT Southwestern researchers have identified a major mechanism by which obesity causes type 2 diabetes, which is a common complication of being overweight that afflicts more than 30 million Americans and over 400 million people worldwide. Researchers found that in obesity, insulin released into the blood by the pancreas is unable to […]Continue Reading ...
December 15, 2017 Porvair Sciences are teaming up with Suzhou Tianlong Bio Technology Co Ltd (China), together with Swansea University and Xi’an Jiaotong University in a collaborative project entitled, “Automating & Stratification of Epigenetics in Healthcare” that is part of the Innovate UK / Jiangsu Industrial Challenge Programme. The project […]Continue Reading ...
Note that some links may require subscriptions. Social media had a field day diagnosing possible causes for President Trump’s recent slurred speech, but the White House says the commander-in-chief is fine and will have a physical early next year. A California woman is suing organ donor networks and a hospital, alleging the pancreas she received […]Continue Reading ...
December 15, 2017 When proteins misfold, accumulate and clump around insulin-producing cells in the pancreas, they kill cells. Now, researchers, including University of Michigan biophysicists, have obtained a structural snapshot of these proteins when they are most toxic, detailing them down to the atomic level. The researchers hope this kind of detail can help in […]Continue Reading ...
December 12, 2017 Open enrollment on the federal health law’s marketplace ends Friday, and most people who want a plan for next year need to meet the deadline. But some consumers who miss the cutoff could be surprised to learn they have the opportunity to enroll later. “While a lot of people will be eligible […]Continue Reading ...
Action Points Note that this observational study suggests that consistently meeting activity guidelines may be protective in terms of incidence of joint symptoms in women. Be aware that regularity of activity was ascertained via self-report, which may introduce recall bias. A large prospective study of physical activity in Australian women has found that modest but […]Continue Reading ...
(HealthDay)—For patients with acute heart failure, adherence to the Mediterranean diet (MedDiet) does not influence long-term mortality, according to a study published online Dec. 6 in JACC: Heart Failure. Òscar Miró, Ph.D., from the University of Barcelona in Spain, and colleagues conducted a prospective study involving patients with acute heart failure in seven Spanish emergency […]Continue Reading ...
- Research uncovers mechanism implicated in defective function of tumor-associated dendritic cells
- OncoBreak: Stubborn Racial Disparities; Paid Medical Leave & Chemo; DIY Gene Tests
- Critical link between obesity and diabetes has been identified
- Transfusion dependence reduces access to high-quality end-of-life care for leukemia patients
- Porvair and Suzhou Tianlong Bio to develop epigenetic analysis technologies
- FDA Approves Ixifi (infliximab-qbtx), a Biosimilar to Remicade
- Morning Break: Trump to Get Check-Up; Cancerous Transplant; Death Knell for MIPS?
- First transcatheter implant for diastolic heart failure successful
- ‘Sushi-like’ nanodiscs provide structural snapshots of misfolding proteins
- Inherited gene variation may be to blame for poor survival of patients with early-onset breast cancer
- Sign-up deadline is Friday, but some people may get extra time
- Higher Booze Taxes Might Pay Off for Public Health
- Regular Activity in Midlife Spares Joints in Women
- Rain May Not Cause Achy Joints After All: MedlinePlus Health News
- MedDiet adherence doesn’t affect acute heart failure mortality
- HKBU experts develop new generation of smart anti-cancer drug molecules
- Chronic Kidney Disease Audit finds wide variations in coding of CKD patients in primary care
- Scientists use nanoparticles to fight Mucoviscidosis
- Increasing physical activity decreases risk of death from lymphoma
- Fear compromises the health, well-being of immigrant families, survey finds